Angiopoietin 1 inhib 
Welcome,         Profile    Billing    Logout  
 2 Companies  2 Products   2 Products   149 Diseases   3 Trials   235 News 


«12...345678910111213...1516»
  • ||||||||||  Journal:  Physiopathology of late-onset fetal growth restriction. (Pubmed Central) -  Oct 30, 2021   
    Another hypothesis suggests that the change in the trophoblastic invasion of spiral arteries would be milder. In this article, we address the main mechanisms described in the pathophysiology of FGR and, later, the specific findings in late-onset FGR.
  • ||||||||||  glibenclamide / Generic mfg.
    Preclinical, Journal:  Efficiency of Gymnema sylvestre-derived gymnemic acid on the restoration and improvement of brain vascular characteristics in diabetic rats. (Pubmed Central) -  Oct 30, 2021   
    Rats were divided into five groups, including control, gymnemic control rats (CGM), rats that were rendered diabetic by single injection of 60 mg/kg streptozotocin (STZ), diabetic rats treated with 400 mg/kg GM (STZ + GM) and diabetic rats treated with 4 mg/kg glibenclamide (GL; STZ + GL)...Furthermore, VEGF expression and Ang-1 secretion decreased in the STZ + GM group compared with STZ rats. The results of the present study revealed that GM treatment decreased blood vessel damage in the brain, suggesting that it may be used as a therapeutic target for the treatment of diabetes.
  • ||||||||||  Journal, PARP Biomarker:  Autophagy Activation by Resveratrol Reduces Severity of Experimental Rheumatoid Arthritis. (Pubmed Central) -  Oct 27, 2021   
    Dietary supplementation with resveratrol induces the non-canonical autophagy pathway and limits the cross-talk existence with inflammation, which in consequence modulates the synovial hyperplasia. Preventive strategies that incorporate dietary intervention with resveratrol may offer a potential therapeutic alternative to drugs to influence the risk of RA and influence its course.
  • ||||||||||  Journal:  Microtubule Stabilization Promotes Microcirculation Reconstruction After Spinal Cord Injury. (Pubmed Central) -  Oct 6, 2021   
    Taken together, this study provides evidence for the mechanisms underlying the promotion of microcirculation reconstruction after SCI by microtubule stabilization treatment. Importantly, this study suggests the potential of microtubule stabilization as a therapeutic target to reduce microcirculation dysfunction after SCI in the clinic.
  • ||||||||||  Journal:  Pathophysiology and underlying mechanisms in Hereditary Angioedema. (Pubmed Central) -  Sep 30, 2021   
    Blood leukocytes of CAP patients with delayed ICU admission show evidence of a more immune suppressive phenotype upon ICU admission when compared with blood leukocytes from patients directly transferred to the ICU. No abstract available
  • ||||||||||  Journal:  Definition and classification of hereditary angioedema. (Pubmed Central) -  Sep 29, 2021   
    It is possible that, after an initial workup, a patient without a family history of HAE could be classified with an acquired form of angioedema (nonhereditary) that may later prove to be HAE due to a de-novo SERPING1 mutation. Because there are forms of nonhistaminergic (H-antihistamine unresponsive) angioedema that appear clinically very similar to HAE, it is essential that the patient undergoes a thorough clinical history and diagnostic evaluation to ensure that he or she is properly diagnosed and classified.
  • ||||||||||  Journal:  Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH). (Pubmed Central) -  Sep 29, 2021   
    The alterations in FXII and plasminogen (also a serine protease inhibited by C1-INH) like with classic HAE are the result of dysregulation of bradykinin generation. Only genetic alterations in angiopoietin-1 may not be related to bradykinin generation, rather related to the control of the effect of bradykinin on the vascular endothelium.
  • ||||||||||  Journal:  RNA-binding protein SAMD4A inhibits breast tumor angiogenesis by modulating the balance of angiogenesis program. (Pubmed Central) -  Sep 16, 2021   
    Mechanistically, SAMD4A was found to specifically destabilize the proangiogenic gene transcripts, including C-X-C motif chemokine ligand 5 (CXCL5), endoglin (ENG), interleukin 1β (IL1β), and angiopoietin 1 (ANGPT1), by directly interacting with the stem-loop structure in the 3' untranslated region (3'UTR) of these mRNAs through its Sterile Alpha Motif (SAM) domain, resulting in the imbalance of angiogenic genes expression. Collectively, our results suggest that SAMD4A is a novel breast tumor suppressor that inhibits tumor angiogenesis by specifically downregulating the expression of proangiogenic genes, which might be a potential anti-angiogenic target for breast cancer therapy.
  • ||||||||||  Preclinical, Journal:  IGFBP-4 enhances VEGF-induced angiogenesis in a mouse model of myocardial infarction. (Pubmed Central) -  Sep 15, 2021   
    Our findings demonstrate that VEGF treatment alone is often not enough to protect against oxidative stress and promote post-ischemic angiogenesis, whereas the combined treatment with IGFBP4 and VEGF can utilize the dual roles of these agents to effectively protect against ischemic and oxidative injury, and promote angiogenesis. These findings provide important insights into the roles of these agents in the clinical setting, and suggest new strategies in the treatment of ischemic heart disease.
  • ||||||||||  A Rare Case of Blue Rubber Bleb Nevus Syndrome (Shoreline Exhibit Hall) -  Sep 8, 2021 - Abstract #ACG2021ACG_78;    
    Severe disease associated with bleeding should be treated with blood transfusions. Refractory disease may benefit from surgical resection of the affected bowel.This case serves to show that BRBNS, although rare, can present in the gastrointestinal system without involvement of other organ systems.Figure: Endoscopy showing multiple nevi in colon
  • ||||||||||  Clinical, Journal:  Angioedema without urticaria: novel findings which must be measured in clinical setting. (Pubmed Central) -  Sep 5, 2021   
    The validation of biomarkers for the contact system activation could be beneficial in differentiating bradykinin - from histaminergic-mediated angioedema. Currently, the available laboratorial tests are still somewhat restricted to the evaluation of the complement activation and the mediators of nonhistaminergic and nonbradykinin-mediated angioedema remain to be identified.
  • ||||||||||  Clinical, Journal:  Plasma cytokines for predicting diabetic retinopathy among type 2 diabetic patients via machine learning algorithms. (Pubmed Central) -  Sep 5, 2021   
    Currently, the available laboratorial tests are still somewhat restricted to the evaluation of the complement activation and the mediators of nonhistaminergic and nonbradykinin-mediated angioedema remain to be identified. Plasma angiopoietin 1, platelet-derived growth factor-BB, and vascular endothelial growth factor receptor 2 were associated with presence of non-proliferative diabetic retinopathy and may be good biomarkers that play important roles in pathophysiology of diabetic retinopathy.
  • ||||||||||  Journal:  CD34+CD146+ adipose-derived stromal cells enhance engraftment of transplanted fat. (Pubmed Central) -  Sep 4, 2021   
    We have identified a subpopulation of CD34+ ASCs with enhanced angiogenic effects in vitro and in vivo, likely mediated by increased expression of potent proangiogenic factors. These findings suggest that enriching lipoaspirate with CD34+CD146+ ASCs may enhance fat graft vascularization and retention in the clinical setting.
  • ||||||||||  Review, Journal:  Advances of Angiopoietin-Tie axis in vascular and lymphatic system-related diseases (Pubmed Central) -  Sep 3, 2021   
    In light of the recent advances on the role of the Ang-Tie axis in vascular and lymphatic system-related diseases, this review summarizes the functions of the Ang-Tie axis in inflammation-induced vascular permeability, vascular remodeling, ocular angiogenesis, shear stress response, atherosclerosis, tumor angiogenesis, and metastasis. Moreover, this review summarizes the relevant therapeutic antibodies, recombinant proteins, and small molecular drugs associated with the Ang-Tie axis.
  • ||||||||||  Clinical, Journal:  Hypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells. (Pubmed Central) -  Sep 2, 2021   
    Hypoxia-inducible factor-1α improves the functional potency of cardiosphere-derived cells to preserve myocardial function after myocardial infarction by enriching the cardiosphere-derived cells' secretome with cardioprotective factors. This strategy may be useful for improving the efficacy of allogeneic cell-based therapies in future clinical trials.
  • ||||||||||  Journal:  Bone Marrow Endothelial Cells Regulate Myelopoiesis in Diabetes. (Pubmed Central) -  Sep 1, 2021   
    Specifically, diabetes reduces endothelial production of Cxcl12, a quiescence-promoting niche factor that reduces stem cell proliferation. We also describe a previously unknown counter-regulatory pathway, in which protective endothelial Egfr signaling curbs HSPC proliferation and myeloid cell production.
  • ||||||||||  Journal:  Effect of erythropoietin on angiogenic potential of dental pulp cells. (Pubmed Central) -  Aug 28, 2021   
    Furthermore, EPO activated the ERK1/2 and p38 signaling pathways in DPCs, while inhibition of these pathways diminished the angiogenesis capacity of DPCs. The present study suggested that EPO may have an important role in the repair and regeneration of dental pulp.
  • ||||||||||  Journal:  Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops. (Pubmed Central) -  Aug 14, 2021   
    PRGF eye drops can be stored for up to 12 months without reduction of the main growth factors and proteins and without any microbial contamination. Furthermore, the biological activity of the PRGF eye drops is maintained after storing for 3 and 7 days at 4°C or at RT.
  • ||||||||||  Clinical, Journal:  Screening for Plasminogen Mutations in Hereditary Angioedema Patients. (Pubmed Central) -  Aug 5, 2021   
    As shown by this study, a biorepository creates the means for the ex-post analysis of recently identified genes in stored DNA samples of the patients. This makes the diagnosis more accurate with the possibility of subsequent family screening and the introduction of appropriate therapy.